Washington Trust CO Brainstorm Cell Therapeutics Inc. Transaction History

Washington Trust CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$1.43 - $3.3 $3,570 - $8,240	2,497 Added 83233.33%	2,500 $8,000
Q1 2023 May 04, 2023	SELL	$1.43 - $3.3 $3,570 - $8,240	-2,497 Reduced 99.88%	3 $8,000
Q1 2020 May 07, 2020	BUY	$4.01 - $8.88 $10,025 - $22,200	2,500 New	2,500 $12,000
Q3 2018 Nov 13, 2018	SELL	$3.73 - $4.38 $9,325 - $10,950	-2,500 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$3.12 - $5.19 $7,800 - $12,975	2,500 New	2,500 $10,000

10.5M

160K

30.5K

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $69.3M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of Washington Trust CO, based on Form 13F filings with the SEC.

Stay updated on Washington Trust CO with notifications on news.